Other Solid Tumors Completed Phase 1 / 2 Trials for Spartalizumab (DB14892)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02404441Phase I/II Study of PDR001 in Patients With Advanced MalignanciesTreatment